Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery

NCT ID: NCT02838173

Last Updated: 2016-07-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compare the "Serratus block plane" (SPB) and the local infiltration of the tissue in the prevention of acute and chronic pain after breast cancer surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chronic pain after breast surgery may be severe, often requiring the use of morphine. The incidence of chronic pain varies from 27 to 50% depending on definitions.

The infiltration of tissues by a local anesthetic is a simple, fast and low risk technique but of limited effectiveness.

Serratus the flat block, performed under ultrasound guidance, is minimally invasive and easy to perform. It allows anesthesia and analgesia to an extended part of the anterolateral chest wall and the axilla. This regional anesthesia technique provides good analgesia during and after breast surgery, but remains to be evaluated; beyond perioperative analgesia, the benefit-risk, post operative rehabilitation, and the impact on ambulatory and on chronic pain are fundamental objectives.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast/Surgery Postoperative Complication Chronic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SPB

Serratus Plane Bloc with Ropivacaine 2mg/ml (0,3ml/kg) and tissue infiltration with placebo made once, by the anesthetist in the operating theater before surgical incision

Group Type EXPERIMENTAL

serratus plane bloc : Ropivacaine 2mg/ml (0,3ml/kg)

Intervention Type PROCEDURE

tissue infiltration : placebo

Intervention Type PROCEDURE

tissue infiltration

tissue infiltration with Ropivacaine 2mg/ml (0,3ml/kg) and Serratus Plane Bloc with placebo made once, by the anesthetist in the operating theater before surgical incision

Group Type ACTIVE_COMPARATOR

tissue infiltration : Ropivacaine 2mg/ml (0,3ml/kg)

Intervention Type PROCEDURE

serratus plane bloc : placebo

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

serratus plane bloc : Ropivacaine 2mg/ml (0,3ml/kg)

Intervention Type PROCEDURE

tissue infiltration : Ropivacaine 2mg/ml (0,3ml/kg)

Intervention Type PROCEDURE

serratus plane bloc : placebo

Intervention Type PROCEDURE

tissue infiltration : placebo

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women scheduled for elective breast neoplasm surgery
* Of ASA classification 1, 2 or 3
* Patients who provide written informed consent

Exclusion Criteria

* Minor patients
* Patients refusing to sign the consent
* Patients included in another protocol within 3 months
* Pregnant or lactating patients
* Patients with history of allergy to local anesthetics (Ropivacaine)
* Patients with contraindication to regional anesthesia (coagulopathy, local infection ...)
* Patients with history of prior breast surgery (excluding diagnostic biopsy)
* Patients with history of chronic pain
* Patients with a history of psychiatric disorder
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erasme University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Céline Boudart

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Luc Van Obbergh, MD PhD

Role: STUDY_DIRECTOR

Erasme hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Céline Boudart, MD

Role: CONTACT

3225553919

Wendy Villareal Fernandez, MD

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anaesthesia. 2013 Nov;68(11):1107-13. doi: 10.1111/anae.12344. Epub 2013 Aug 7.

Reference Type BACKGROUND
PMID: 23923989 (View on PubMed)

Andreae MH, Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis. Br J Anaesth. 2013 Nov;111(5):711-20. doi: 10.1093/bja/aet213. Epub 2013 Jun 28.

Reference Type BACKGROUND
PMID: 23811426 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B406201628750

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ESP in Breast Surgery Due to Cancer
NCT04726878 COMPLETED PHASE4